Nortriptyline Sanoswiss (Nortriptyline Hydrochloride)

Nortriptyline, the active ingredient in Nortriptyline Sanoswiss, is a tricyclic antidepressant presented as an oral tablet for systemic use. It is prescribed for the treatment of depressive disorders in adults, helping to improve mood and alleviate associated symptoms.

GNH USA supplies Nortriptyline Sanoswiss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. Our distribution network enables reliable delivery to diverse healthcare settings, supporting patient care continuity.

Nortriptyline is a tricyclic antidepressant that acts on mood‑regulating pathways and is indicated for several recognized conditions. - Major depressive disorder: reduces depressive symptoms and improves overall mood. - Depressive episodes in bipolar disorder (adjunct): helps stabilize mood when used alongside mood stabilizers. - Neuropathic pain (e.g., diabetic peripheral neuropathy): provides analgesic relief by modulating pain pathways.

Common Side Effects: - Dry mouth: reduced salivary secretion. - Constipation: slowed gastrointestinal motility. - Drowsiness or sedation: central nervous system depressant effect. - Weight gain: increased appetite or metabolic changes. - Blurred vision: anticholinergic activity. - Orthostatic hypotension: blood pressure drop on standing.

Serious or Rare Side Effects: - Cardiac arrhythmias: especially in patients with pre‑existing heart disease. - Seizures: lowered seizure threshold. - Severe hyponatremia: syndrome of inappropriate antidiuretic hormone secretion. - Hepatotoxicity: abnormal liver function tests. - Neuroleptic malignant‑like syndrome: rare but life‑threatening reaction. - Allergic reactions: rash, angioedema, or anaphylaxis.

Nortriptyline should be used with caution in specific clinical situations. - Cardiac monitoring: assess ECG in patients with known heart disease. - Seizure risk: avoid in individuals with a history of seizures. - Electrolyte balance: monitor sodium levels, particularly in the elderly. - Drug‑induced hyponatremia: watch for signs of low sodium. - Pregnancy and lactation: evaluate risk‑benefit before prescribing. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Nortriptyline can interact with several medications, requiring careful management. Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis or serotonin syndrome. - SSRIs or SNRIs: increased serotonin levels may precipitate serotonin syndrome. - Anticholinergic drugs: additive anticholinergic burden. Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise nortriptyline plasma concentrations. - CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation. - Diuretics: potential for electrolyte disturbances, especially hyponatremia.